BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37195345)

  • 1. Evolution in the management of vestibular schwannoma: a single-center 15-year experience.
    El Sayed Ahmad Y; Gallois Y; Sol JC; Boetto S; Attal J; Sabatier J; Debs R; Deguine O; Marx M
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4885-4894. PubMed ID: 37195345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Clinicians Should Consider to Determine a More Beneficial Treatment Strategy for Small to Medium Sized Vestibular Schwannoma With Serviceable Hearing: A Single Surgeon's Long-term Outcome of Microsurgery and Gamma Knife Radiosurgery.
    Han MS; Jung S; Lim SH; Kim IY; Moon KS; Jung TY; Jang WY
    Otol Neurotol; 2020 Sep; 41(8):1122-1130. PubMed ID: 32569150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
    Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
    J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision Making on Vestibular Schwannoma: Lessons from a Multidisciplinary Board.
    Sergi B; Balducci M; Paludetti G; Olivi A; Picciotti PM; De Corso E; Passali GC; Fetoni AR; Lucidi D
    World Neurosurg; 2022 Jan; 157():e506-e513. PubMed ID: 34710576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.
    Andrews DW; Suarez O; Goldman HW; Downes MB; Bednarz G; Corn BW; Werner-Wasik M; Rosenstock J; Curran WJ
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1265-78. PubMed ID: 11483338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.
    Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma.
    Shirato H; Sakamoto T; Sawamura Y; Kagei K; Isu T; Kato T; Fukuda S; Suzuki K; Soma S; Inuyama Y; Miyasaka K
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):545-50. PubMed ID: 10348283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy in three weekly fractions for the management of vestibular schwannomas.
    Gallogly JA; Jumaily M; Faraji F; Mikulec AA
    Am J Otolaryngol; 2018; 39(5):561-566. PubMed ID: 29961654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study.
    Pikis S; Mantziaris G; Kormath Anand R; Nabeel AM; Sheehan D; Sheehan K; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad Eldin R; Peker S; Samanci Y; Kaisman-Elbaz T; Speckter H; Hernández W; Isidor J; Tripathi M; Madan R; Zacharia BE; Daggubati LC; Martínez Moreno N; Martínez Álvarez R; Langlois AM; Mathieu D; Deibert CP; Sudhakar VR; Cifarelli CP; Arteaga Icaza D; Cifarelli DT; Wei Z; Niranjan A; Barnett GH; Lunsford LD; Bowden GN; Sheehan JP
    J Neurosurg; 2023 Feb; 138(2):405-412. PubMed ID: 36303474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system.
    Rueß D; Pöhlmann L; Grau S; Hamisch C; Hoevels M; Treuer H; Baues C; Kocher M; Ruge M
    Sci Rep; 2020 Jun; 10(1):9309. PubMed ID: 32518238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Treatment of Small to Medium (<3 cm) Sporadic Vestibular Schwannomas: A Systematic Review and Meta-Analysis on Hearing Preservation and Tumor Control Rates for Microsurgery versus Radiosurgery.
    Savardekar AR; Terrell D; Lele SJ; Diaz R; Keesari PR; Trosclair K; Kosty J; Wang CJ; Gardner G; Guthikonda B
    World Neurosurg; 2022 Apr; 160():102-113.e12. PubMed ID: 34838768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of vestibular schwannomas after failed radiation treatment.
    Nonaka Y; Fukushima T; Watanabe K; Friedman AH; Cunningham CD; Zomorodi AR
    Neurosurg Rev; 2016 Apr; 39(2):303-12; discussion 312. PubMed ID: 26782633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].
    Hamm K; Herold HU; Surber G; Rosahl S
    HNO; 2017 May; 65(5):434-442. PubMed ID: 28078405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlargement of a vestibular schwannoma after stereotactic radiotherapy.
    Couldwell WT; Mohan AL
    Acta Neurochir (Wien); 2002 Dec; 144(12):1319-22. PubMed ID: 12478345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes in patients treated with CyberKnife radiosurgery for vestibular schwannoma.
    Vivas EX; Wegner R; Conley G; Torok J; Heron DE; Kabolizadeh P; Burton S; Ozhasoglu C; Quinn A; Hirsch BE
    Otol Neurotol; 2014 Jan; 35(1):162-70. PubMed ID: 24335934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption.
    Sawamura Y; Shirato H; Sakamoto T; Aoyama H; Suzuki K; Onimaru R; Isu T; Fukuda S; Miyasaka K
    J Neurosurg; 2003 Oct; 99(4):685-92. PubMed ID: 14567604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.